These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11921407)

  • 1. De novo design, synthesis, and in vitro evaluation of inhibitors for prokaryotic tRNA-guanine transglycosylase: a dramatic sulfur effect on binding affinity.
    Meyer EA; Brenk R; Castellano RK; Furler M; Klebe G; Diederich F
    Chembiochem; 2002 Mar; 3(2-3):250-3. PubMed ID: 11921407
    [No Abstract]   [Full Text] [Related]  

  • 2. A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase.
    Grädler U; Gerber HD; Goodenough-Lashua DM; Garcia GA; Ficner R; Reuter K; Stubbs MT; Klebe G
    J Mol Biol; 2001 Feb; 306(3):455-67. PubMed ID: 11178905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of specificity determinants in bacterial tRNA-guanine transglycosylase reveals queuine, the substrate of its eucaryotic counterpart, as inhibitor.
    Biela I; Tidten-Luksch N; Immekus F; Glinca S; Nguyen TX; Gerber HD; Heine A; Klebe G; Reuter K
    PLoS One; 2013; 8(5):e64240. PubMed ID: 23704982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
    Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
    J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.
    Ritschel T; Kohler PC; Neudert G; Heine A; Diederich F; Klebe G
    ChemMedChem; 2009 Dec; 4(12):2012-23. PubMed ID: 19894214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity inhibitors of Zymomonas mobilis tRNA-guanine transglycosylase through convergent optimization.
    Barandun LJ; Immekus F; Kohler PC; Ritschel T; Heine A; Orlando P; Klebe G; Diederich F
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1798-807. PubMed ID: 23999303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
    Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
    Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From lin-benzoguanines to lin-benzohypoxanthines as ligands for Zymomonas mobilis tRNA-guanine transglycosylase: replacement of protein-ligand hydrogen bonding by importing water clusters.
    Barandun LJ; Immekus F; Kohler PC; Tonazzi S; Wagner B; Wendelspiess S; Ritschel T; Heine A; Kansy M; Klebe G; Diederich F
    Chemistry; 2012 Jul; 18(30):9246-57. PubMed ID: 22736391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Immucillin-Based Transition-State-Analogous Inhibitor of tRNA-Guanine Transglycosylase (TGT).
    Hohn C; Härtsch A; Ehrmann FR; Pfaffeneder T; Trapp N; Dumele O; Klebe G; Diederich F
    Chemistry; 2016 May; 22(20):6750-4. PubMed ID: 26991861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding.
    Stengl B; Meyer EA; Heine A; Brenk R; Diederich F; Klebe G
    J Mol Biol; 2007 Jul; 370(3):492-511. PubMed ID: 17524419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding.
    Hörtner SR; Ritschel T; Stengl B; Kramer C; Schweizer WB; Wagner B; Kansy M; Klebe G; Diederich F
    Angew Chem Int Ed Engl; 2007; 46(43):8266-9. PubMed ID: 17902085
    [No Abstract]   [Full Text] [Related]  

  • 12. Soaking suggests "alternative facts": Only co-crystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition.
    Ehrmann FR; Stojko J; Metz A; Debaene F; Barandun LJ; Heine A; Diederich F; Cianférani S; Reuter K; Klebe G
    PLoS One; 2017; 12(4):e0175723. PubMed ID: 28419165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis.
    Brenk R; Naerum L; Grädler U; Gerber HD; Garcia GA; Reuter K; Stubbs MT; Klebe G
    J Med Chem; 2003 Mar; 46(7):1133-43. PubMed ID: 12646024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Launching spiking ligands into a protein-protein interface: a promising strategy to destabilize and break interface formation in a tRNA modifying enzyme.
    Immekus F; Barandun LJ; Betz M; Debaene F; Petiot S; Sanglier-Cianferani S; Reuter K; Diederich F; Klebe G
    ACS Chem Biol; 2013; 8(6):1163-78. PubMed ID: 23534552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase reveal aspartate 102 as the active site nucleophile.
    Romier C; Reuter K; Suck D; Ficner R
    Biochemistry; 1996 Dec; 35(49):15734-9. PubMed ID: 8961936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase to elucidate the role of serine 103 for enzymatic activity.
    Grädler U; Ficner R; Garcia GA; Stubbs MT; Klebe G; Reuter K
    FEBS Lett; 1999 Jul; 454(1-2):142-6. PubMed ID: 10413112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragments as Novel Starting Points for tRNA-Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies.
    Hassaan E; Eriksson PO; Geschwindner S; Heine A; Klebe G
    ChemMedChem; 2020 Feb; 15(3):324-337. PubMed ID: 31808981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible adaptations in the structure of the tRNA-modifying enzyme tRNA-guanine transglycosylase and their implications for substrate selectivity, reaction mechanism and structure-based drug design.
    Brenk R; Stubbs MT; Heine A; Reuter K; Klebe G
    Chembiochem; 2003 Oct; 4(10):1066-77. PubMed ID: 14523925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of water molecules in a phosphate binding site by furanoside-appended lin-benzoguanine ligands of tRNA-guanine transglycosylase (TGT).
    Barandun LJ; Ehrmann FR; Zimmerli D; Immekus F; Giroud M; Grünenfelder C; Schweizer WB; Bernet B; Betz M; Heine A; Klebe G; Diederich F
    Chemistry; 2015 Jan; 21(1):126-35. PubMed ID: 25483606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swapping Interface Contacts in the Homodimeric tRNA-Guanine Transglycosylase: An Option for Functional Regulation.
    Ehrmann FR; Kalim J; Pfaffeneder T; Bernet B; Hohn C; Schäfer E; Botzanowski T; Cianférani S; Heine A; Reuter K; Diederich F; Klebe G
    Angew Chem Int Ed Engl; 2018 Aug; 57(32):10085-10090. PubMed ID: 29927035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.